Since tirzepatide is already approved and well known, doctors have a solid basis for talking about how it can be used to treat obesity
Heres who might be able to use them: Adults With Higher BMI You might qualify for GLP-1 weight loss medication if: Your BMI is 30 or higher, or Your BMI is 27 or higher and you have weight-related health problems BMI (Body Mass Index) is a way to measure if your weight might affect your health
Many people starting tirzepatide notice that sulfur burps can be particularly intense during the first few weeks at each new dose level
Over half of corporate and multiemployer/public plans cover GLP-1s for diabetes only, while roughly one-third in each group extend coverage to both diabetes and weight loss
Yes, transitioning between weekly shots and daily oral weight loss medication is clinically possible
This could lower total Medicare spending on semaglutide products, including Ozempic, Rybelsus, and Wegovy